Jointly presented by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing


Supported by educational grants from Eli Lilly and Company, AstraZeneca and Novo Nordisk, Inc.

dkb header

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes; The TECOS Study Group

a podcast by Kathleen Dungan, MD, MPH and Jennifer Green, MD dkb icon

You are using an outdated browser. Please upgrade your browser or activate Google Chrome Frame to improve your experience.